TMBIM1 and metabolic dysfunction-associated steatohepatitis: TMBIM1 has been shown to be protective against non-alcoholic fatty liver disease (NAFLD), progression to non-alcoholic steatohepatitis, and insulin resistance in mice and macaques [49].